New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

RSPHvsFXHETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.1%
VS
ETF 2
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.1%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) and First Trust Health Care AlphaDEX Fund ETF (FXH) belong to the same industry segment: US Health Care. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, FXH's top sector exposures are Healthcare. RSPH is less expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.61% for FXH. RSPH is up 26.32% year-to-date (YTD) with +$66M in YTD flows. FXH performs worse with 21.67% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of RSPH and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs FXH performance and flow charts

Performance

0246810%Oct 2Oct 9Oct 16Oct 23Oct 30

Cumulative Flows

-40 M-20 M0 M20 M40 MOct 2Oct 9Oct 16Oct 23Oct 30

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 11/03/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
FXH
+7.38%+6.30%
+14.07%+7.90%
+26.32%+21.67%
+33.11%+24.45%
+54.19%+52.31%
+33.18%+15.44%
Flows
RSPH
FXH
+$38M-$39M
+$109M+$20M
+$66M+$33M
+$64M+$39M
-$215M-$445M
-$191M-$464M
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
FXH
+18.14%+14.89%
+16.85%+15.68%
+15.88%+15.66%
+16.81%+16.95%
Max drawdown
RSPH
FXH
-5.57%-4.82%
-10.87%-12.07%
-16.96%-17.66%
-21.91%-27.47%
Max drawdown duration
RSPH
FXH
55d55d
116d168d
434d395d
817d1638d
Trading data

Create an account to view trading data

Join for free
RSPH
FXH
Last sale
11/4/2026 at 7:05 PM
$41.49
$143.04
Previous close
11/03/2026
$39.98
$137.97
Consolidated volume
11/03/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
RSPH
FXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 11/4/2026 at 7:05 PM
Live
Closed
RSPH
FXH
Last price
$41.49
$143.04
1D performance
+3.78%
+3.67%
AuM$996.11 M$1.16 B
E/R0.4%0.61%
Characteristics
RSPH
FXH
Management strategyPassivePassive
ProviderInvescoFirst Trust
BenchmarkS&P 500 Equal Weight Health Care IndexStrataQuant Health Care Index
N° of holdings6072
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006May 8, 2007
ESGNoNo
Advertisement
Exposure

Countries

RSPH
USA
96.84%
Other
3.16%
FXH
USA
93.54%
Other
6.46%

Sectors

RSPH
Healthcare
98.51%
Other
1.49%
FXH
Healthcare
98.5%
Other
1.5%

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%
FXH

Total weight of top 15 holdings out of 15

35.85%

Top 15 holdings

Data as of September 30, 2026
RSPH
Moderna, Inc.
2.35%
Illumina, Inc.
2.14%
Revvity, Inc.
1.97%
Agilent Technologies, Inc.
1.96%
Mettler-Toledo International, Inc.
1.94%
Intuitive Surgical, Inc.
1.90%
Thermo Fisher Scientific, Inc.
1.81%
West Pharmaceutical Services, Inc.
1.80%
Danaher Corp.
1.79%
Viatris, Inc.
1.79%
Waters Corp.
1.77%
Biogen, Inc.
1.75%
Veeva Systems, Inc.
1.74%
Amgen, Inc.
1.73%
AbbVie, Inc.
1.71%
FXH
Natera, Inc.
3.34%
Universal Health Services, Inc.
2.62%
Regeneron Pharmaceuticals, Inc.
2.62%
Pfizer Inc.
2.60%
Guardant Health, Inc.
2.59%
Solventum Corp.
2.53%
Zimmer Biomet Holdings, Inc.
2.27%
Halozyme Therapeutics, Inc.
2.27%
Tenet Healthcare Corp.
2.25%
Boston Scientific Corp.
2.25%
Corcept Therapeutics, Inc.
2.18%
The Cigna Group
2.16%
Centene Corp.
2.11%
Globus Medical, Inc.
2.09%
Medline, Inc.
1.97%
Frequently asked questions about RSPH and FXH

How have the RSPH and FXH ETFs performed in 2026?

As of November 3, 2026, RSPH is up 26.32% year-to-date (YTD), while FXH has returned 21.67%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or FXH?

Year-to-date, the RSPH ETF saw +$66M in flows, compared to +$33M for FXH.

Which ETF is more volatile: RSPH or FXH?

Over the past year, RSPH had a volatility of 16.85%, while FXH experienced 15.68%.

Which ETF is bigger: RSPH or FXH?

As of November 3, 2026, RSPH holds $996.11 M in assets under management (AUM), while FXH manages $1.16 B.

What sectors do the RSPH and FXH ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.

What are the top holdings of the RSPH ETF and FXH ETF?

RSPH top holdings include Moderna, Inc., Illumina, Inc. and Revvity, Inc.. FXH holds in its top three: Natera, Inc., Universal Health Services, Inc. and Regeneron Pharmaceuticals, Inc..

Which ETF is more diversified: RSPH or FXH?

RSPH holds 60 securities with 28.14% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.85%.

Advertisement
Latest news about RSPH & FXH
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026